Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation to Assess the Effect of Betaglucan Administration in HPV Patients

NCT06987396 is registered in ClinicalTrials.gov with Vitae Health Innovation as lead sponsor.

NCT NCT06987396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06987396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation to Assess the Effect of Betaglucan Administration in HPV Patients
Lead sponsor
Vitae Health Innovation
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2023
Completion date
May 15, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv